| - GRCh37:
- Chr5:42695063
- GRCh38:
- Chr5:42694961
| GHR | Y104C, Y82C, Y111C | Laron-type isolated somatotropin defect | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695061
- GRCh38:
- Chr5:42694959
| GHR | D103E, D110E, D81E | Laron-type isolated somatotropin defect | Uncertain significance (Oct 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42693862-42695083
- GRCh38:
- Chr5:42693760-42694981
| GHR | | Laron-type isolated somatotropin defect | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr5:42711413
- GRCh38:
- Chr5:42711311
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42699970
- GRCh38:
- Chr5:42699868
| GHR | V140F, V162F, V169F | not provided, Short stature due to partial GHR deficiency, Hypercholesterolemia, familial, 1, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Oct 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42566051
- GRCh38:
- Chr5:42565949
| GHR | | Laron-type isolated somatotropin defect | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr5:42689044-42689045
- GRCh38:
- Chr5:42688942-42688943
| GHR | S43fs, S65fs, S72fs | Laron-type isolated somatotropin defect | Pathogenic (Dec 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720358
- GRCh38:
- Chr5:42720256
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720250
- GRCh38:
- Chr5:42720148
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42718611
- GRCh38:
- Chr5:42718509
| GHR | | Laron-type isolated somatotropin defect, not provided | Conflicting interpretations of pathogenicity (May 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42713560
- GRCh38:
- Chr5:42713458
| GHR | I250V, I279V, I272V | Laron-type isolated somatotropin defect, not provided | Uncertain significance (Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42711433
- GRCh38:
- Chr5:42711331
| GHR | Y226C, Y248C, Y255C | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42711414
- GRCh38:
- Chr5:42711312
| GHR | E220K, E242K, E249K | Laron-type isolated somatotropin defect, not provided | Uncertain significance (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42423919
- GRCh38:
- Chr5:42423817
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423893
- GRCh38:
- Chr5:42423791
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721902
- GRCh38:
- Chr5:42721800
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721462
- GRCh38:
- Chr5:42721360
| GHR | | Laron-type isolated somatotropin defect | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720060
- GRCh38:
- Chr5:42719958
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720000
- GRCh38:
- Chr5:42719898
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719987
- GRCh38:
- Chr5:42719885
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719916
- GRCh38:
- Chr5:42719814
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719587
- GRCh38:
- Chr5:42719485
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42699972
- GRCh38:
- Chr5:42699870
| GHR | | not provided, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42721323
- GRCh38:
- Chr5:42721221
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721273
- GRCh38:
- Chr5:42721171
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719354
- GRCh38:
- Chr5:42719252
| GHR | G582E, G560E, G589E | Laron-type isolated somatotropin defect, not provided | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42719273
- GRCh38:
- Chr5:42719171
| GHR | H533R, H555R, H562R | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42699919
- GRCh38:
- Chr5:42699817
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695016
- GRCh38:
- Chr5:42694914
| GHR | | Laron-type isolated somatotropin defect, not provided | Conflicting interpretations of pathogenicity (Sep 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42689024
- GRCh38:
- Chr5:42688922
| GHR | R35C, R57C, R64C | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721137
- GRCh38:
- Chr5:42721035
| GHR | | Laron-type isolated somatotropin defect | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721057
- GRCh38:
- Chr5:42720955
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720558
- GRCh38:
- Chr5:42720456
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719210
- GRCh38:
- Chr5:42719108
| GHR | Y512C, Y541C, Y534C | Laron-type isolated somatotropin defect | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42566044
- GRCh38:
- Chr5:42565942
| GHR | E23G, E30G | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42565971
- GRCh38:
- Chr5:42565869
| GHR | T6A | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42424030
- GRCh38:
- Chr5:42423928
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423995
- GRCh38:
- Chr5:42423893
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423993
- GRCh38:
- Chr5:42423891
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423980
- GRCh38:
- Chr5:42423878
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423951
- GRCh38:
- Chr5:42423849
| GHR, LOC107963950 | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695017
- GRCh38:
- Chr5:42694915
| GHR | | Laron-type isolated somatotropin defect | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695096
- GRCh38:
- Chr5:42694994
| GHR | N115T, N122T, N93T | Laron-type isolated somatotropin defect | Likely pathogenic (Oct 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42629151
- GRCh38:
- Chr5:42629049
| GHR | I28V, I35V | not provided, Inborn genetic diseases, Laron-type isolated somatotropin defect
| Conflicting interpretations of pathogenicity (Feb 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42718755
- GRCh38:
- Chr5:42718653
| GHR | | not provided, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42719151
- GRCh38:
- Chr5:42719049
| GHR | C492W, C521W, C514W | not provided, Laron-type isolated somatotropin defect | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42629168
- GRCh38:
- Chr5:42629066
| GHR | | Laron-type isolated somatotropin defect, not specified, not provided
| Conflicting interpretations of pathogenicity (Dec 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42718223
- GRCh38:
- Chr5:42718121
| GHR | | Laron-type isolated somatotropin defect | Pathogenic (Jan 4, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695116
- GRCh38:
- Chr5:42695014
| GHR | W122R, W129R, W100R | not provided | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42565988
- GRCh38:
- Chr5:42565886
| GHR | W4C, W11C | Laron-type isolated somatotropin defect | Uncertain significance (Mar 30, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr5:42695033
- GRCh38:
- Chr5:42694931
| GHR | W94*, W101*, W72* | Laron-type isolated somatotropin defect | Pathogenic (Nov 4, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr5:42721820
- GRCh38:
- Chr5:42721718
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721818
- GRCh38:
- Chr5:42721716
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721695
- GRCh38:
- Chr5:42721593
| GHR | | Laron-type isolated somatotropin defect | Likely benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721568
- GRCh38:
- Chr5:42721466
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721544
- GRCh38:
- Chr5:42721442
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721460
- GRCh38:
- Chr5:42721358
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721442
- GRCh38:
- Chr5:42721340
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721418
- GRCh38:
- Chr5:42721316
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721373
- GRCh38:
- Chr5:42721271
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721316
- GRCh38:
- Chr5:42721214
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721296
- GRCh38:
- Chr5:42721194
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721215
- GRCh38:
- Chr5:42721113
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721080
- GRCh38:
- Chr5:42720978
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721065
- GRCh38:
- Chr5:42720963
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42721024-42721026
- GRCh38:
- Chr5:42720922-42720924
| GHR | | Laron-type isolated somatotropin defect | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720776-42720779
- GRCh38:
- Chr5:42720674-42720677
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720507
- GRCh38:
- Chr5:42720405
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720467
- GRCh38:
- Chr5:42720365
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720439
- GRCh38:
- Chr5:42720337
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720362
- GRCh38:
- Chr5:42720260
| GHR | | Laron-type isolated somatotropin defect | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720307
- GRCh38:
- Chr5:42720205
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720219
- GRCh38:
- Chr5:42720117
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720218
- GRCh38:
- Chr5:42720116
| GHR | | Laron-type isolated somatotropin defect | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720196
- GRCh38:
- Chr5:42720094
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720155
- GRCh38:
- Chr5:42720053
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42720068-42720069
- GRCh38:
- Chr5:42719966-42719967
| GHR | | Laron-type isolated somatotropin defect | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719890
- GRCh38:
- Chr5:42719788
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719826
- GRCh38:
- Chr5:42719724
| GHR | | not provided, Laron-type isolated somatotropin defect | Benign (Nov 12, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42719680
- GRCh38:
- Chr5:42719578
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719562
- GRCh38:
- Chr5:42719460
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719508
- GRCh38:
- Chr5:42719406
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719441
- GRCh38:
- Chr5:42719339
| GHR | A611V, A618V, A589V | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719397
- GRCh38:
- Chr5:42719295
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719308
- GRCh38:
- Chr5:42719206
| GHR | I567F, I574F, I545F | not provided, Laron-type isolated somatotropin defect | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42719249
- GRCh38:
- Chr5:42719147
| GHR | A547V, A525V, A554V | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42719092
- GRCh38:
- Chr5:42718990
| GHR | P495T, P473T, P502T | not provided, Laron-type isolated somatotropin defect | Benign/Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42718634
- GRCh38:
- Chr5:42718532
| GHR | W342L, W349L, W320L | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42718139
- GRCh38:
- Chr5:42718037
| GHR | | not provided, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42713631
- GRCh38:
- Chr5:42713529
| GHR | | not provided, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42711350
- GRCh38:
- Chr5:42711248
| GHR | L220F, L198F, L227F | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42695025
- GRCh38:
- Chr5:42694923
| GHR | | not provided, Laron-type isolated somatotropin defect | Conflicting interpretations of pathogenicity (Oct 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42689061
- GRCh38:
- Chr5:42688959
| GHR | T69I, T47I, T76I | not provided, Laron-type isolated somatotropin defect, not specified
| Conflicting interpretations of pathogenicity (Feb 3, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42689037
- GRCh38:
- Chr5:42688935
| GHR | R61Q, R68Q, R39Q | Laron-type isolated somatotropin defect | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42565967
- GRCh38:
- Chr5:42565865
| GHR | | Laron-type isolated somatotropin defect | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:42423905
- GRCh38:
- Chr5:42423803
| GHR, LOC107963950 | | not provided, Laron-type isolated somatotropin defect | Benign (Jun 11, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42711376
- GRCh38:
- Chr5:42711274
| GHR | R229H, R236H, R207H | Laron-type isolated somatotropin defect, Short stature due to partial GHR deficiency, not specified, not provided | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:42719344
- GRCh38:
- Chr5:42719242
| GHR | P579T, P557T, P586T | not specified, not provided, Laron-type isolated somatotropin defect
| Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42718928
- GRCh38:
- Chr5:42718826
| GHR | C440F, C447F, C418F | not specified, not provided, Laron-type isolated somatotropin defect
| Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:42713522
- GRCh38:
- Chr5:42713420
| GHR | | Laron-type isolated somatotropin defect, not specified, not provided
| Benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |